| Oral Corticosteroid Use in Asthma: Recognizing the Risks and Reducing Overuse |
|
|
|
| Latest News | |||
| Thursday, December 11, 2025 02:19 PM | |||
Oral Corticosteroid Use in Asthma: Recognizing the Risks and Reducing OveruseContent from the Michigan Department of Health and Human Services Do your patients overuse oral corticosteroids (OCS)? While OCS can be an important tool in managing asthma in certain cases, use should always be carefully monitored by a qualified asthma specialist, or a primary care provider with asthma expertise. OCS carry serious health risks – just four bursts of steroids or 1–2.5 grams of OCS over a lifetime can increase a patient’s risk for serious side effects. Even short-term, low-dose use of OCS (under 30 days) can result in serious health problems, doubling the risk for fracture, tripling the risk for blood clots, and increasing sepsis risk fivefold. Other long-term effects include cataracts, high blood sugar (which can trigger or worsen diabetes), infections, osteoporosis and thin skin, bruising, and slower wound healing. OCS use is a signal that a patient may need an updated treatment plan or additional support with medication adherence. Conventional medications often include inhaled corticosteroids (ICS), which result in much lower overall steroid exposure than even one course of OCS. What can you do to help prevent OCS overuse? Educate your patients and their caregivers about:
Sometimes these conversations are hard to start, and patients may want a “quick fix” for their symptoms. These resources can help:
|